Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon

por Thieu, Vivian T., Mitchell, Beth D., Varnado, Oralee J., Frier, Brian M.
Publicado 2020

Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin

por Peng, Xiaomei, Jiang, Dingfeng, Liu, Dongju, Varnado, Oralee J, Bae, Jay P
Publicado 2016

Health care resource utilization and costs associated with treatment among patients initiating calcitonin gene–related peptide inhibitors vs other preventive migraine treatments in...

por Varnado, Oralee J, Manjelievskaia, Janna, Ye, Wenyu, Perry, Allison, Schuh, Kory, Wenzel, Richard
Publicado 2022

Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claim...

por Varnado, Oralee J, Manjelievskaia, Janna, Ye, Wenyu, Perry, Allison, Schuh, Kory, Wenzel, Richard
Publicado 2022

Cardiovascular outcomes trials with glucagon‐like peptide‐1 receptor agonists: A comparison of study designs, populations and results

por Pantalone, Kevin M., Munir, Kashif, Hasenour, Clinton M., Atisso, Charles M., Varnado, Oralee J., Maldonado, Juan M., Konig, Manige
Publicado 2020

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial

por Riddle, Matthew C, Gerstein, Hertzel C, Xavier, Denis, Cushman, William C, Leiter, Lawrence A, Raubenheimer, Peter J, Atisso, Charles M, Raha, Sohini, Varnado, Oralee J, Konig, Manige, Lakshmanan, Mark, Franek, Edward
Publicado 2021